Image
16.02.2024
Our first Community and Events Impact Report celebrates our top achiev...
We are thrilled to be sharing our first Community and Events Impact Report, which celebrates all the amaz...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more